يعرض 1 - 20 نتائج من 104 نتيجة بحث عن '"Washington University School of Medicine, St Louis, Missouri"', وقت الاستعلام: 0.60s تنقيح النتائج
  1. 1
  2. 2
    Academic Journal
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Electronic Resource

    المؤلفون: Department of Surgery, St. Joseph Mercy Hospital, Ann Arbor, Michigan ; Department of Surgery, University of Michigan, Ann Arbor, Michigan, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts ; Department of Pathology, Harvard Medical School, Boston, Massachusetts ; Department of Pathology, Brigham and Women's Hospital, 75 Francis St., Boston, MA 02115, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts ; Department of Medicine, Harvard Medical School, Boston, Massachusetts, Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts ; Department of Radiology, Harvard Medical School, Boston, Massachusetts, Department of Pathology, University Hospital ???12 de Octubre???, Madrid, Spain, Department of Pathology, Harvard Medical School, Boston, Massachusetts ; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, Department of Pathology, University of California San Francisco, San Francisco, California, Department of Pathology, University of Colorado at Denver, Aurora, Colorado, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, Cibas, Edmund S., Alexander, Erik K., Benson, Carol B., De Agust??n, Pedro Patricio, Doherty, Gerard M., Faquin, William C., Middleton, William D., Miller, Theodore, Raab, Stephen S., White, Matthew L., Mandel, Susan J.

  10. 10
    Academic Journal
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
    Academic Journal

    المساهمون: Institut Català de la Salut, Stradella A Institut Català d'Oncologia–Hospital Duran I Reynals, L'Hospitalet de Llobregat, Catalunya, Spain. Johnson M Sarah Cannon Research Institute, Tennessee Oncology, PLLC, Nashville, Tennessee, USA. Goel S Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA. Park H Washington University School of Medicine, St. Louis, Missouri, USA. Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Lakhani N START Midwest, Grand Rapids, Michigan, USA. Arkenau HT Sarah Cannon Research Institute, UCL Cancer Institute, University College London, London, UK. Saavedra O Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Cancer Medicine;13(13); https://doi.org/10.1002/cam4.7385; Stradella A, Johnson M, Goel S, Park H, Lakhani N, Arkenau HT, et al. Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors. Cancer Med. 2024 Jul;13(13):e7385.; https://hdl.handle.net/11351/11694

  16. 16
    Academic Journal

    المساهمون: Institut Català de la Salut, Mutch D Division of Gynecology Oncology, Washington University School of Medicine, St Louis, Missouri, USA. Voulgari A Global Product Development Clinical Science, Roche Products Ltd., Welwyn Garden City, UK. Chen XM Translational Medicine, Genentech, Inc., South San Francisco, California, USA. Bradley WH Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Oaknin A Medical Oncology Service, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Perez Fidalgo JA Hospital Clínico Universitario Valencia, Biomedical Research Institute INCLIVA, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Valencia, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    مصطلحات موضوعية: Quimioteràpia combinada, Ovaris - Càncer - Immunoteràpia, Anticossos monoclonals - Ús terapèutic, DISEASES::Neoplasms::Neoplasms by Site::Endocrine Gland Neoplasms::Ovarian Neoplasms, Other subheadings::Other subheadings::Other subheadings::/drug therapy, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents::Antineoplastic Agents, Immunological, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal::Antibodies, Monoclonal, Humanized, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de las glándulas endocrinas::neoplasias ováricas, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos::inmunoterapia antineoplásica, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales::anticuerpos monoclonales humanizados

    وصف الملف: application/pdf

    Relation: Cancer;130(11); https://doi.org/10.1002/cncr.35222; Mutch D, Voulgari A, Chen XM, Bradley WH, Oaknin A, Perez Fidalgo JA, et al. Primary results and characterization of patients with exceptional outcomes in a phase 1b study combining PARP and MEK inhibition, with or without anti–PD-L1, for BRCA wild-type, platinum-sensitive, recurrent ovarian cancer. Cancer. 2024 Jun 1;130(11):1940–51.; https://hdl.handle.net/11351/11533; 001153827700001

  17. 17
    Academic Journal

    المساهمون: Institut Català de la Salut, Oh ST Division of Hematology, Washington University School of Medicine, St. Louis, Missouri, USA. Verstovsek S Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Gupta V Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. Platzbecker U Clinic of Hematology, Cellular Therapy, and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany. Devos T Microbiology, and Immunology, Laboratory of Molecular Immunology (Rega Institute), Department of Hematology, University Hospitals Leuven and Department of Microbiology and Immunology, Laboratory of Molecular Immunology (Rega Institute), KU Leuven, Leuven, Belgium. Kiladjian JJ Université Paris Cité, AP-HP, Hopital Saint-Louis, Centre d’Investigations Cliniques, Paris, France. Fox ML Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: eJHaem;5(1); https://doi.org/10.1002/jha2.854; Oh ST, Verstovsek S, Gupta V, Platzbecker U, Devos T, Kiladjian JJ, et al. Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis. eJHaem. 2024 Feb 5;5(1):105–16.; https://hdl.handle.net/11351/11154

  18. 18
    Academic Journal

    المساهمون: Institut Català de la Salut, Cortellini A Department of Surgery & Cancer, Hammersmith Hospital Campus, Imperial College London, London, UK. Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy. Dettorre GM Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA. Dafni U Laboratory of Biostatistics, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece. Aguilar-Company J Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei de Malalties Infeccioses, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Castelo-Branco L Scientific and Medical Division, ESMO (European Society for Medical Oncology), Lugano, Switzerland. NOVA National School of Publich Health, NOVA University, Lisbon, Portugal. Lambertini M Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genoa, Genova, Italy. Medical Oncology Department, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Journal for ImmunoTherapy of Cancer;10(11); http://dx.doi.org/10.1136/jitc-2022-005732; Cortellini A, Dettorre GM, Dafni U, Aguilar-Company J, Castelo-Branco L, Lambertini M, et al. Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries. J Immunother Cancer. 2022 Nov;10(11):e005732.; https://hdl.handle.net/11351/8618

  19. 19
    Academic Journal

    المساهمون: Institut Català de la Salut, Regalado ES, Hostetler EM Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center at Houston (UTHealth), Houston, Texas, USA. Morris SA Division of Pediatric Cardiology, Baylor College of Medicine, Houston, Texas, USA. Braverman AC Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA. De Backer J Department of Cardiology and Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium. European Reference Network for Rare Multisystemic Vascular Disease (VASCERN), Heritable Thoracic Aortic Disease Working Group. Li R Department of Biostatistics and Data Science, School of Public Health, UTHealth, Houston, Texas, USA. Evangelista A European Reference Network for Rare Multisystemic Vascular Disease (VASCERN), Heritable Thoracic Aortic Disease Working Group. Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBER-CV, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Journal of the American College of Cardiology;80(9); https://doi.org/10.1016/j.jacc.2022.05.054; Regalado ES, Morris SA, Braverman AC, Hostetler EM, De Backer J, Li R, et al. Comparative Risks of Initial Aortic Events Associated With Genetic Thoracic Aortic Disease. J Am Coll Cardiol. 2022 Aug 30;80(9):857–69.; https://hdl.handle.net/11351/8431; 000861033600001

  20. 20
    Academic Journal

    المساهمون: Department of Ophthalmology and Visual Sciences (PL, JBH, MOG, GPVS), Washington University School of Medicine, St. Louis, Missouri, Mallinckrodt Institute of Radiology (MG), Washington University School of Medicine, St. Louis, Missouri, and Department of Neurology (MG, GPVS), Washington University School of Medicine, St. Louis, Missouri

    المصدر: Journal of Neuro-Ophthalmology, June 2019, Volume 39, Issue 2